NeuroBo Pharmaceuticals   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Boston MA United States (2017)

Organization Overview

First Clinical Trial
2020
NCT04603924
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ANA Therapeutics | NeuroBo Pharmaceuticals | NeuroBo Pharmaceuticals Inc.